Hem › Rabdomyosarkom › Kalifornien
Kliniska studier för Rabdomyosarkom i Kalifornien
7 studier för Rabdomyosarkom söker deltagare vid platser i Kalifornien.
Officiell studietext (engelska)
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- UCSF Benioff Children's Hospital, San Francisco
RekryterarFas 1
24 Months – 18 Years · Alla kön · Uppdaterad 25 sep. 2026 · NCT06441331Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- UCSF Benioff Children's Hospital Oakland, Oakland
- Rady Children's Hospital, San Diego
RekryterarFas 1/2
Upp till ålder 30 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06541262A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- City of Hope Comprehensive Cancer Center, Duarte
- Loma Linda University Medical Center, Loma Linda
- Cedars-Sinai Medical Center, Los Angeles
- och 4 fler
RekryterarFas 3
Upp till ålder 50 · Alla kön · Uppdaterad 25 aug. 2026 · NCT07466316Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
RekryterarTidig fas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 31 juli 2026 · NCT07628634PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Cedars-Sinai Medical Center, Los Angeles
- University of California, San Francisco, San Francisco
RekryterarFas 1/2
Ålder 1 till 30 · Alla kön · Uppdaterad 22 juli 2026 · NCT06721689Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
- Stanford University, Palo Alto
RekryterarFas 2
Upp till ålder 22 · Alla kön · Uppdaterad 15 juni 2026 · NCT06023641Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 19 maj 2026 · NCT04901702Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.